Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Fast track – JSH2023 OSAKA: Current evidence and perspectives for hypertension management in Asia
  • Published:

Nocturnal systolic blood pressure dipping and progression of chronic kidney disease

Abstract

The relationship between declining nocturnal blood pressure (BP) and adverse cardiovascular outcomes is well-recognized. However, the relationship between diurnal BP profile and the risk of chronic kidney disease (CKD) progression is unclear. Herein, we examined the association between nocturnal systolic SBP (SBP) dipping and CKD progression in 1061 participants at the Cardiovascular and Metabolic Disease Etiology Research Center-High Risk (CMERC-HI). The main exposure was diurnal systolic BP (SBP) profile and diurnal SBP difference ([nighttime SBP-daytime SBP] × 100/daytime SBP). The primary outcome was CKD progression, defined as a composite of ≥ a 50% decline in the estimated glomerular filtration rate from baseline or the initiation of kidney replacement therapy. During 4749 person-years of follow-up (median, 4.8 years), the composite outcome occurred in 380 (35.8%) participants. Compared to dippers, the hazard ratios (HRs) for the risk of adverse kidney outcomes were 1.02 (95% confidence interval [CI], 0.64–1.62), 1.30 (95% CI, 1.02–1.66), and 1.40 (95% CI, 1.03–1.90) for extreme dipper, non-dipper, and reverse dipper, respectively. In a continuous modeling, a 10% increase in diurnal SBP difference was associated with a 1.21-fold (95% CI, 1.07–1.37) higher risk of CKD progression. Thus, decreased nocturnal SBP decline was associated with adverse kidney outcomes in patients with CKD. Particularly, patients with non-dipping and reverse dipping patterns were at higher risk for CKD progression than those with a dipping pattern.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. USRD System. 2021 USRDS Annual Data Report: epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2021.

  2. Lee JY, Park JT, Joo YS, Lee C, Yun HR, Yoo TH, et al. Association of blood pressure with the progression of CKD: findings from KNOW-CKD study. Am J Kidney Dis. 2021;78:236–45.

    Article  PubMed  Google Scholar 

  3. Blood Pressure Lowering Treatment Trialists’ Collaboration, Ninomiya T, Perkovic V, Turnbull F, Neal B, Barzi F, et al. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. BMJ. 2013;347:f5680.

  4. Malhotra R, Nguyen HA, Benavente O, Mete M, Howard BV, Mant J, et al. Association between more intensive vs less intensive blood pressure lowering and risk of mortality in chronic kidney disease stages 3 to 5: a systematic review and meta-analysis. JAMA Intern Med. 2017;177:1498–505.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kidney Disease: Improving Global Outcomes Blood Pressure Work Group. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99:S1–87.

    Article  Google Scholar 

  6. Cohen JB, Lotito MJ, Trivedi UK, Denker MG, Cohen DL, Townsend RR. Cardiovascular events and mortality in white coat hypertension: a systematic review and meta-analysis. Ann Intern Med. 2019;170:853–62.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Pierdomenico SD, Pierdomenico AM, Coccina F, Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of masked uncontrolled hypertension. Hypertension. 2018;72:862–9.

    Article  CAS  PubMed  Google Scholar 

  8. Son HE, Ryu JY, Go S, Yi Y, Kim K, Oh YK, et al. Association of ambulatory blood pressure monitoring with renal outcome in patients with chronic kidney disease. Kidney Res Clin Pr. 2020;39:70–80.

    Article  Google Scholar 

  9. Pickering TG. The clinical significance of diurnal blood pressure variations. Dippers and nondippers. Circulation. 1990;81:700–2.

    Article  CAS  PubMed  Google Scholar 

  10. Bankir L, Bochud M, Maillard M, Bovet P, Gabriel A, Burnier M. Nighttime blood pressure and nocturnal dipping are associated with daytime urinary sodium excretion in African subjects. Hypertension. 2008;51:891–8.

    Article  CAS  PubMed  Google Scholar 

  11. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990;81:528–36.

    Article  CAS  PubMed  Google Scholar 

  12. Tadic M, Cuspidi C, Pencic B, Ivanovic B, Scepanovic R, Marjanovic T, et al. Circadian blood pressure pattern and right ventricular and right atrial mechanics: a two- and three-dimensional echocardiographic study. J Am Soc Hypertens. 2014;8:45–53.

    Article  PubMed  Google Scholar 

  13. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Bjorklund-Bodegard K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219–29.

    Article  PubMed  Google Scholar 

  14. Salles GF, Reboldi G, Fagard RH, Cardoso CR, Pierdomenico SD, Verdecchia P, et al. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: The Ambulatory Blood Pressure Collaboration in Patients With Hypertension (ABC-H) Meta-Analysis. Hypertension. 2016;67:693–700.

    Article  CAS  PubMed  Google Scholar 

  15. Debella YT, Giduma HD, Light RP, Agarwal R. Chronic kidney disease as a coronary disease equivalent—a comparison with diabetes over a decade. Clin J Am Soc Nephrol. 2011;6:1385–92.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Briasoulis A, Bakris GL. Chronic kidney disease as a coronary artery disease risk equivalent. Curr Cardiol Rep. 2013;15:340.

    Article  PubMed  Google Scholar 

  17. Mojón A, Ayala DE, Piñeiro L, Otero A, Crespo JJ, Moyá A, et al. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol Int. 2013;30:145–58.

    Article  PubMed  Google Scholar 

  18. Cho SMJ, Lee H, Yoo TH, Jhee JH, Park S, Kim HC. Association between nocturnal blood pressure dipping and chronic kidney disease among patients with controlled office blood pressure. Am J Hypertens. 2021;34:821–30.

    Article  PubMed  Google Scholar 

  19. Agarwal R, Andersen MJ. Blood pressure recordings within and outside the clinic and cardiovascular events in chronic kidney disease. Am J Nephrol. 2006;26:503–10.

    Article  PubMed  Google Scholar 

  20. Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, et al. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med. 2011;171:1090–8.

    Article  PubMed  Google Scholar 

  21. Rahman M, Wang X, Bundy JD, Charleston J, Cohen D, Cohen J, et al. Prognostic significance of ambulatory BP monitoring in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. 2020;31:2609–21.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Levy D, Kannel WB. Cardiovascular risks: new insights from Framingham. Am Heart J. 1988;116:266–72.

    Article  CAS  PubMed  Google Scholar 

  23. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol. 2003;14:2934–41.

    Article  PubMed  Google Scholar 

  24. Jung HH. Albuminuria, estimated glomerular filtration rate, and traditional predictors for composite cardiovascular and kidney outcome: a population-based cohort study in Korea. Kidney Res Clin Pr. 2022;41:567–79.

    Article  Google Scholar 

  25. Kado H, Kusaba T, Matoba S, Hatta T, Tamagaki K. Normotensive non-dipping blood pressure profile does not predict the risk of chronic kidney disease progression. Hypertens Res. 2019;42:354–61.

    Article  PubMed  Google Scholar 

  26. Gabbai FB, Rahman M, Hu B, Appel LJ, Charleston J, Contreras G, et al. Relationship between ambulatory BP and clinical outcomes in patients with hypertensive CKD. Clin J Am Soc Nephrol. 2012;7:1770–6.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Borrelli S, Garofalo C, Gabbai FB, Chiodini P, Signoriello S, Paoletti E, et al. Dipping status, ambulatory blood pressure control, cardiovascular disease, and kidney disease progression: a multicenter cohort study of CKD. Am J Kidney Dis. 2022;81:15–24.e1.

    Article  PubMed  Google Scholar 

  28. Shim JS, Song BM, Lee JH, Lee SW, Park JH, Choi DP, et al. Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) cohort: study protocol and results of the first 3 years of enrollment. Epidemiol Health. 2017;39:e2017016.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.

    Article  PubMed  PubMed Central  Google Scholar 

  30. O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731–68.

    Article  CAS  PubMed  Google Scholar 

  31. Pogue V, Rahman M, Lipkowitz M, Toto R, Miller E, Faulkner M, et al. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension. 2009;53:20–7.

    Article  CAS  PubMed  Google Scholar 

  32. Braun WJ, Huang L-S. Kernel spline regression. Can J Stat/La Revue Canadienne de Statistique. 2005;33:259–78.

    Article  Google Scholar 

  33. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Himmelfarb CD, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Hypertension. 2018;71:e13–115.

    CAS  PubMed  Google Scholar 

  34. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953–2041.

    Article  CAS  PubMed  Google Scholar 

  35. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens. 1994;7:23–9.

    Article  CAS  PubMed  Google Scholar 

  36. Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Bombelli M, Cuspidi C, et al. Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives. Hypertension. 2008;52:925–31.

    Article  CAS  PubMed  Google Scholar 

  37. Myredal A, Friberg P, Johansson M. Elevated myocardial repolarization lability and arterial baroreflex dysfunction in healthy individuals with nondipping blood pressure pattern. Am J Hypertens. 2010;23:255–9.

    Article  PubMed  Google Scholar 

  38. Sachdeva A, Weder AB. Nocturnal sodium excretion, blood pressure dipping, and sodium sensitivity. Hypertension. 2006;48:527–33.

    Article  CAS  PubMed  Google Scholar 

  39. Shin J, Lee CH. The roles of sodium and volume overload on hypertension in chronic kidney disease. Kidney Res Clin Pr. 2021;40:542–54.

    Article  Google Scholar 

  40. von Kanel R, Jain S, Mills PJ, Nelesen RA, Adler KA, Hong S, et al. Relation of nocturnal blood pressure dipping to cellular adhesion, inflammation and hemostasis. J Hypertens. 2004;22:2087–93.

    Article  Google Scholar 

  41. Castelpoggi CH, Pereira VS, Fiszman R, Cardoso CR, Muxfeldt ES, Salles GF. A blunted decrease in nocturnal blood pressure is independently associated with increased aortic stiffness in patients with resistant hypertension. Hypertens Res. 2009;32:591–6.

    Article  PubMed  Google Scholar 

  42. Satoh M, Kikuya M, Ohkubo T, Mori T, Metoki H, Hashimoto T, et al. Aldosterone-to-renin ratio and nocturnal blood pressure decline in a general population: the Ohasama study. J Hypertens. 2011;29:1940–7.

    Article  CAS  PubMed  Google Scholar 

  43. Minutolo R, Gabbai FB, Chiodini P, Garofalo C, Stanzione G, Liberti ME, et al. Reassessment of ambulatory blood pressure improves renal risk stratification in nondialysis chronic kidney disease: long-term cohort study. Hypertension. 2015;66:557–62.

    Article  CAS  PubMed  Google Scholar 

  44. Wang C, Ye Z, Li Y, Zhang J, Zhang Q, Ma X, et al. Prognostic value of reverse dipper blood pressure pattern in chronic kidney disease patients not undergoing dialysis: prospective cohort study. Sci Rep. 2016;6:34932.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This research was supported by the “National Institute of Health” research project (project No. 2021-ER0903-02; SP) and a grant from the Korean Health Technology Research and Development Project through the Korean Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant number HI13C0715; SP) and by a research program funded by the Korea Disease Control and Prevention Agency (grant number 2021-ER0903-02; SP). This research was also supported by the Main Research Program (grant number E0210601-03; SP) of the Korea Food Research Institute, funded by the Korean Ministry of Science and ICT. The funders of this study had no role in study design, data collection, analysis, reporting, or the decision to submit for publication.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Sungha Park or Tae-Hyun Yoo.

Ethics declarations

Conflict of interest

The opinions, results, and conclusions are those of the authors and are independent from this funding and data sources. All the authors declared no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, C.H., Jhee, J.H., Chun, KH. et al. Nocturnal systolic blood pressure dipping and progression of chronic kidney disease. Hypertens Res 47, 215–224 (2024). https://doi.org/10.1038/s41440-023-01368-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-023-01368-x

Keywords

Search

Quick links